The main technology of Metafines , called ‘ASCA101’ is related to new pharmacological composition for cancer treatment. ‘ASCA101’ is metabolic anti-cancer drug that has excellent therapeutic effect by disrupting the metabolic processes of working cancer cells in duplicate and complex ways through different mechanisms are acted in each cancer cell due to simultaneous uptake of different compounds to cancer cells. And also, ‘ASCA101’ is less susceptible to drug resistance, which can more effectively inhibit the effects of cancer cells such as proliferation, infiltration, and metastasis.

• ASCA101

• Inducing Cytotoxicity,
  Apoptosis with
  Cancer Cell
  Selectivity

  Low-Toxic Drug
  Repositioning NCE

  Inducing Cytotoxicity,
  Apoptosis with
  Cancer Cell
  Selectivity

  Anti-cancer Drug of
  complex mechanism
  (ATP depletion,
  ROS increase)

  *NCE : New Chemical Entities